(Q36282260)

13 August 2017

1 reference

title

Expanding treatment of tobacco dependence (English)

1 reference

13 August 2017

Debra S Harris

1

1 reference

13 August 2017

Robert M Anthenelli

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Current Psychiatry Reports

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

344-351

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-005-0034-3

13 August 2017

exact match

0 references

cites work

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-005-0034-3

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-005-0034-3

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation

21 January 2018

1 reference

12 December 2020

Low monoamine oxidase B in peripheral organs in smokers

1 reference

12 December 2020

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

12 December 2020

Absorption and presystemic metabolism of selegiline hydrochloride at different regions in the gastrointestinal tract in healthy males

1 reference

12 December 2020

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

1 reference

12 December 2020

A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation

1 reference

12 December 2020

Clonidine for smoking cessation

1 reference

12 December 2020

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

1 reference

12 December 2020

Psychopharmacological interactions between nicotine and ethanol

1 reference

12 December 2020

Cellular mechanisms of nicotine addiction

1 reference

12 December 2020

Topiramate blocks kainate-evoked cobalt influx into cultured neurons

1 reference

12 December 2020

Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms

1 reference

12 December 2020

Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

1 reference

12 December 2020

Effects of mecamylamine on human cigarette smoking and subjective ratings

1 reference

12 December 2020

Mecamylamine acutely increases human intravenous nicotine self-administration

1 reference

12 December 2020

Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats

1 reference

12 December 2020

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

1 reference

12 December 2020

Modulating tobacco smoking rates by dopaminergic stimulation and blockade

1 reference

12 December 2020

Toxicokinetic evaluation of a selegiline transdermal system in the dog.

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of selegiline. An update

1 reference

12 December 2020

Nicotine replacement therapy for smoking cessation

1 reference

12 December 2020

Negative affect and smoking lapses: a prospective analysis.

1 reference

12 December 2020

Monoamine oxidases and tobacco smoking

1 reference

12 December 2020

Mecamylamine does not precipitate withdrawal in cigarette smokers.

1 reference

12 December 2020

Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.

1 reference

12 December 2020

Advances in pharmacotherapy for tobacco dependence.

1 reference

12 December 2020

A systematic review of the effectiveness of brief interventions with substance using adolescents by type of drug.

1 reference

12 December 2020

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

1 reference

12 December 2020

The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].

1 reference

12 December 2020

Antidepressants for smoking cessation

1 reference

12 December 2020

Effects of haloperidol on reactions to smoking cues in humans.

1 reference

12 December 2020

Olanzapine attenuates cue-elicited craving for tobacco

1 reference

12 December 2020

A pharmacologic strategy for the treatment of nicotine addiction

1 reference

12 December 2020

Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level

1 reference

12 December 2020

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

1 reference

12 December 2020

Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE)

1 reference

12 December 2020

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

1 reference

12 December 2020

Effects of selegiline (L-deprenyl) during smoking and short-term abstinence

1 reference

12 December 2020

Meta-analysis of the efficacy of tobacco counseling by health care providers

1 reference

12 December 2020

Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice

1 reference

12 December 2020

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

1 reference

12 December 2020

Topiramate selectively attenuates nicotine-induced increases in monoamine release

1 reference

12 December 2020

Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the Collaborative Study on the Genetics of Alcoholism

1 reference

12 December 2020

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

1 reference

12 December 2020

Acute nicotinic blockade produces cognitive impairment in normal humans.

1 reference

12 December 2020

Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine

1 reference

12 December 2020

Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction

1 reference

12 December 2020

The world health report 2002 - reducing risks, promoting healthy life

1 reference

12 December 2020

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

12 December 2020

Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes

1 reference

12 December 2020

Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.

1 reference

12 December 2020

Bupropion is a nicotinic antagonist.

1 reference

12 December 2020

1 reference

12 December 2020

Brief interventions: good in theory but weak in practice.

1 reference

12 December 2020

Overview of nicotinic receptors and their roles in the central nervous system

1 reference

12 December 2020

Current pharmacological treatments for nicotine dependence

1 reference

12 December 2020

Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments

1 reference

12 December 2020

10.1007/S11920-005-0034-3

Identifiers

DOI

1 reference

13 August 2017

1 reference